Plain-English translation of NCT06018714 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a medication called can help prevent colorectal cancer from coming back after surgery. works by reducing the blood supply that tumors need to grow. Researchers want to see if taking this medication for six months after you've finished chemotherapy can keep cancer from returning longer than standard care alone.
Even after surgery successfully removes all signs of colorectal cancer from the liver, more than 60% of patients experience cancer recurrence. Current treatments given after surgery don't fully prevent this from happening, so researchers are testing whether this medication might help protect against recurrence and give patients more time before cancer returns.
You would take the medication by mouth daily for up to six months, or until your cancer returns or side effects become too difficult. During this time, you would have regular check-ups including blood tests every three months, imaging scans (CT or MRI) every six months, and a colonoscopy once per year. If any signs of cancer returning are found, additional imaging or procedures may be done.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
China